BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37848358)

  • 1. Distinguishing characteristics of pediatric patients with primary hyperoxaluria type 1 in PEDSnet.
    Tasian GE; Dickinson K; Park G; Marchesani N; Mittal A; Cheng N; Ching CB; Chu DI; Walton R; Yonekawa K; Gluck C; Muneeruddin S; Kan KM; DeFoor W; Rove K; Forrest CB
    J Pediatr Urol; 2024 Feb; 20(1):88.e1-88.e9. PubMed ID: 37848358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive evaluation of patients with primary hyperoxaluria type 1: A nationwide study.
    Bakkaloğlu SA; Büyükkaragöz B; Pınarbaşı AS; Leventoğlu E; Saygılı S; Çomak E; Yıldırım ZY; Akıncı N; Dursun İ; Karabay Bayazıt A; Kavaz Tufan A; Akman S; Yılmaz A; Noyan A; Ağbaş A; Serdaroğlu E; Delibaş A; Elmacı AM; Taşdemir M; Ezgü FS; Sever L
    Nephrology (Carlton); 2024 Apr; 29(4):201-213. PubMed ID: 38290500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary hyperoxaluria type 1 in children: clinical and laboratory manifestations and outcome.
    Wannous H
    Pediatr Nephrol; 2023 Aug; 38(8):2643-2648. PubMed ID: 36917293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical analysis of seven cases with primary hyperoxaluria type 1 in children].
    Liao X; Li YJ; Zhong F; Chen Y; Tan M; Liao YR; Gao Y
    Zhonghua Er Ke Za Zhi; 2020 Feb; 58(2):129-134. PubMed ID: 32102150
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical spectrum of primary hyperoxaluria type 1: Experience of a tertiary center.
    Soliman NA; Nabhan MM; Abdelrahman SM; Abdelaziz H; Helmy R; Ghanim K; Bazaraa HM; Badr AM; Tolba OA; Kotb MA; Eweeda KM; Fayez A
    Nephrol Ther; 2017 May; 13(3):176-182. PubMed ID: 28161266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.
    Michael M; Groothoff JW; Shasha-Lavsky H; Lieske JC; Frishberg Y; Simkova E; Sellier-Leclerc AL; Devresse A; Guebre-Egziabher F; Bakkaloglu SA; Mourani C; Saqan R; Singer R; Willey R; Habtemariam B; Gansner JM; Bhan I; McGregor T; Magen D
    Am J Kidney Dis; 2023 Feb; 81(2):145-155.e1. PubMed ID: 35843439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated GFR Slope Across CKD Stages in Primary Hyperoxaluria Type 1.
    Singh P; Vaughan LE; Schulte PJ; Sas DJ; Milliner DS; Lieske JC
    Am J Kidney Dis; 2022 Sep; 80(3):373-382. PubMed ID: 35306035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic policies on nephrolithiasis/nephrocalcinosis of possible genetic origin by Italian nephrologists: a survey by the Italian Society of Nephrology with an emphasis on primary hyperoxaluria.
    Ferraro PM; Caletti C; Capolongo G; Lombardi M; Scolari F; Vezzoli G; Vitale C; Gambaro G
    J Nephrol; 2023 Jul; 36(6):1605-1614. PubMed ID: 37358729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of urine and plasma oxalate in children with primary hyperoxaluria type 1.
    Sas DJ; Mara K; Mehta RA; Seide BM; Banks CJ; Danese DS; McGregor TL; Lieske JC; Milliner DS
    Pediatr Nephrol; 2024 Jan; 39(1):141-148. PubMed ID: 37458799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characterization of primary hyperoxaluria type 3 in comparison with types 1 and 2.
    Singh P; Viehman JK; Mehta RA; Cogal AG; Hasadsri L; Oglesbee D; Olson JB; Seide BM; Sas DJ; Harris PC; Lieske JC; Milliner DS
    Nephrol Dial Transplant; 2022 Apr; 37(5):869-875. PubMed ID: 33543760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific populations of urinary extracellular vesicles and proteins differentiate type 1 primary hyperoxaluria patients without and with nephrocalcinosis or kidney stones.
    Jayachandran M; Yuzhakov SV; Kumar S; Larson NB; Enders FT; Milliner DS; Rule AD; Lieske JC
    Orphanet J Rare Dis; 2020 Nov; 15(1):319. PubMed ID: 33176829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late diagnosis of primary hyperoxaluria after failed kidney transplantation.
    Spasovski G; Beck BB; Blau N; Hoppe B; Tasic V
    Int Urol Nephrol; 2010 Sep; 42(3):825-9. PubMed ID: 20020206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and functional analysis of human SLC26A6 variants in patients with familial hyperoxaluria and calcium oxalate nephrolithiasis.
    Monico CG; Weinstein A; Jiang Z; Rohlinger AL; Cogal AG; Bjornson BB; Olson JB; Bergstralh EJ; Milliner DS; Aronson PS
    Am J Kidney Dis; 2008 Dec; 52(6):1096-103. PubMed ID: 18951670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria.
    Tang X; Bergstralh EJ; Mehta RA; Vrtiska TJ; Milliner DS; Lieske JC
    Kidney Int; 2015 Mar; 87(3):623-31. PubMed ID: 25229337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and characterization of a novel rat model of primary hyperoxaluria type 1 with a nonsense mutation in alanine-glyoxylate aminotransferase gene.
    Li Y; Zheng R; Xu G; Huang Y; Li Y; Li D; Geng H
    Am J Physiol Renal Physiol; 2021 Mar; 320(3):F475-F484. PubMed ID: 33491567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative assessment of the patient experience of primary hyperoxaluria type 1: an observational study.
    Danese D; Goss D; Romano C; Gupta C
    BMC Nephrol; 2023 Oct; 24(1):319. PubMed ID: 37884879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I.
    Worcester EM; Evan AP; Coe FL; Lingeman JE; Krambeck A; Sommers A; Phillips CL; Milliner D
    Am J Physiol Renal Physiol; 2013 Dec; 305(11):F1574-84. PubMed ID: 24089413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined liver-kidney transplantation for primary hyperoxaluria type 1 in young children.
    Ellis SR; Hulton SA; McKiernan PJ; de Ville de Goyet J; Kelly DA
    Nephrol Dial Transplant; 2001 Feb; 16(2):348-54. PubMed ID: 11158411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Hyperoxaluria Type 1 (PH1) Presenting With End-Stage Kidney Disease and Cutaneous Manifestations in Adulthood: A Case Report.
    Poyah P; Bergman J; Geldenhuys L; Wright G; Walsh NM; Hull P; Roche K; West ML
    Can J Kidney Health Dis; 2021; 8():20543581211058931. PubMed ID: 34840803
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.